Corrigendum to "The chemotherapeutic potential of doxorubicin-loaded PEG-b-PLGA nanopolymersomes in mouse breast cancer model." [Eur. J. Pharm. Biopharm. 94 (2015) 521-531].

Corrigendum to "The chemotherapeutic potential of doxorubicin-loaded PEG-b-PLGA nanopolymersomes in mouse breast cancer model." [Eur. J. Pharm. Biopharm. 94 (2015) 521-531]. Eur J Pharm Biopharm. 2019 Sep;142:540 Authors: Alibolandi M, Sadeghi F, Abnous K, Atyabi F, Ramezani M, Hadizadeh F PMID: 31470967 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/31470967?dopt=Abstract

Source: European Journal of Pharmaceutics and Biopharmaceutics - August 31, 2019 Category: Drugs & Pharmacology Authors: Alibolandi M, Sadeghi F, Abnous K, Atyabi F, Ramezani M, Hadizadeh F Tags: Eur J Pharm Biopharm Source Type: research